Premium
NICE on the use of cannabis‐based medicinal products
Author(s) -
Chaplin Steve
Publication year - 2020
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1838
Subject(s) - medicine , dravet syndrome , clobazam , cannabidiol , lennox–gastaut syndrome , nice , nausea , vomiting , cannabis , epilepsy , anesthesia , psychiatry , computer science , programming language
This article provides a summary of the recent NICE recommendations on the use of cannabis‐based medicinal products (CBMPs) in the treatment of epilepsy, spasticity, pain, and nausea and vomiting. It also discusses the guidance on cannabidiol (Epidyolex) plus clobazam for the treatment of Dravet syndrome and Lennox‐Gastaut syndrome, two rare forms of epilepsy.